Increased High Sensitive CRP Level and Its Significance in Pathogenesis of Slow Coronary Flow

Abstract

Previous studies have suggested that microvascular abnormalities cause slow coronary flow (SCF). The role of inflammation has not been investigated, to date. The purpose of this study was to determine the role of inflammation in pathogenesis of SCF. The study included 32 patients with angiographically proven SCF (mean age 49 ±9 years) (group I) and 30 subjects with normal coronary flow (mean age 48 ±8 years) (group II). Blood samples were collected for high sensitive CRP (hs-CRP) measurements. Thrombolysis in myocardial infarction frame count (TFC) was compared in both groups. Distribution of sex, age, body mass index (BMI), arterial blood pressure, and ejection fraction were similar in the 2 groups. TFC was significantly higher in group I than in group II for each artery including left anterior descending coronary artery (LAD), left circumflex artery (Cx), and right coronary artery (RCA) (38.9 ±6.6 vs 22.1 ±1.8 frames, p = 0.0001; 39.6 ±4.9 vs 22.3 ±1.8 frames, p = 0.001 ; 39.0 ±3.8 vs 22.0 ±1.8 frames, p = 0.001, respectively). In group I, serum hs-CRP concentration was significantly higher than that of group II (0.6 ±0.58 vs 0.24 ±0.1 mg/dL p = 0.03). Correlation analysis showed a positive correlation between hs-CRP level and TFC for each artery (for CTFC_LAD, r = 0.36 p = 0.004; for TFC_Cx, r = 0.42 p = 0.003; and for TFC_RCA, r = 0.42, p = 0.0001 respectively). Increased hs-CRP level suggests that inflammation may be associated with pathogenesis of SCF or at least in part contributes to its pathogenesis. Increased hs-CRP level may also be an early marker of impaired coronary blood flow.

Get full access to this article

View all access options for this article.

References

Tambe AA , Demany MA , Zimmerman HA , et al: Angina pectoris and slow flow velocity of dye in coronary arteries. A new angiographic finding. Am Heart J 84:66-71, 1972.

Mosseri M. , Yarom R. , Gotsman MS , et al: Histologic evidence for small-vessel coronary artery disease in patients with angina pectoris and patent large coronary arteries. Circulation 5:964-972, 1986.

Mangieri E. , Macchiarelli G. , Ciavolella M. , et al: Slow coronary flow: Clinical and histopathological features in patients with otherwise normal epicardial coronary arteries. Cathet Cardiovasc Diagn 37:375-381, 1996.

Sezgin AT , Sigirci A. , Barutcu I. , et al: Vascular endothelial function in patients with slow coronary flow. Coron Artery Dis 14:155-161, 2003.

Ridker P. : Fibrinolytic end inflammatory markers for arterial occlusion: The evolving epidemiology of thrombosis and hemostasis. Thromb Haemost 78:53-59, 1997.

Kuller LH , Tracy RP , Shaten J. , et al: Relation of C-reactive protein and coronary heart disease in the MRFIT nested case-control study. Multiple Risk Factor Interventional Trial . Am J Epidemiol 144:537-554, 1996.

Ridker PM , Cushman M. , Stampfer MJ , et al: Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med 336: 973-979, 1997.

Fichtlscherer S. , Rosenberger G. , Walter DH , et al: Elevated C-reactive protein levels and impaired endothelial vasoreactivity in patients with coronary artery disease . Circulation 102:1000-1006, 2000 .

Pasceri V. , Willerson JT , Yeh ET : Direct proinflammatory effect of C-reactive protein on human cells. Circulation 102:2165-2168, 2000 .

10.

Torzewski M. , Rist C. , Mortensen RF , et al: C-reactive protein in the arterial intima: Role of C-reactive protein receptor-dependent monocyte recruitment in atherogenesis. Arterioscler Thromb Vasc Biol 20: 2094-2099, 2000.

11.

Gibson CM , Cannon CP , Daley WL , et al: For the TIMI 4 Study Group. TIMI frame count: A quantitative method of assessing coronary artery flow. Circulation 93:879-888, 1996.

12.

Tracy PP , Lemaitre RN , Psaty BM , et al: Relationship of C-reactive protein to risk of cardiovascular disease in the elderly: Results from the Cardiovascular Health Study and the Rural Health Promotion Project. Arterioscler Thromb Vasc Biol 17:1121-1127, 1997.

13.

Macy EM , Hayes TE , Tracy RP : Variability in the measurement of C-reactive protein in healthy subjects: Implications for reference interval and epidemiological applications. Clin Chem 43:1:52-58, 1997.

14.

Kapoor A. , Goel PK , Gupta S. : Slow coronary flow — a cause for angina with ST segment elevation and normal coronary arteries. A case report. Int J Cardiol 67:257-261, 1998.

15.

Przbojewski J. , Becker PH : Angina pectoris and acute myocardial infarction due to “slow-flow phenomenon ” in nonatherosclerotic coronary arteries. A case report. Angiology 37:751-761, 1986.

16.

Cesar Cam , Ramires JA , Serrana CV Jr, et al: Slow coronary runoff in patients with angina pectoris: Clinical significance and thallium 201 scintigraphic study. Braz J Med Biol Res 29:605-613, 1996.

17.

Legrand V. , Hudgson J McB , Bates ER , et al: Abnormal coronary flow reserve and abnormal radionuclide exercise test results in patients with normal coronary angiograms. J Am Coll Cardiol 6:1245-1253, 1985.

18.

Haverkate F. , Thombson SG , Pyke Sdm , for the European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group : Production of C-reactive protein and risk of coronary events in stable and unstable angina. Lancet 349:462-466, 1997.

19.

Torzewski J. , Torzewski M. , Bowyer DE , et al: C-reactive protein frequently colocalizes with the terminal complement complex in the intima of early atherosclerotic lesions of human coronary arteries. Arterioscler Thromb Vasc Biol 18:1386-1392, 1998 .

20.

Ross R. : The pathogenesis of atherosclerosis: A perspective for the 1999s. Nature 362:802-809, 1993.

21.

Van der Wal AC , Becker AE , van der Loos CM , et al: Site of the intimal rupture of erosion of thrombosed coronary atherosclerotic plaques is characterized by an inflammatory process irrespective of dominant plaque morphology. Circulation 89:36-44, 1994.

22.

Ridker PM , Glynn RJ , Hennekens CH : C-reactive protein adds to the predictive value of total and HDL cholesterol in determining risk of first myocardial infarction. Circulation 97:2007-2011, 1998.

23.

Sothern RB , Roitman-Johnsen B. , Kanabrocki EL , et al: Circadian characteristics of circulating interleukin-6 in men . J Allergy Clin Immunol 95:1029-1035, 1995 .

24.

Meier-Ewert HK , Ridker PM , Rifai N. , et al: Absence of diurnal variation of C-reactive protein concentration in healthy human subjects. Clin Chem 47:426-430, 2001.

25.

Erren M. , Reinecke H. , Junker R. , et al: Systemic inflammatory parameters in patients with atherosclerosis of the coronary and peripheral arteries. Arterioscler Thromb Vasc Biol 19:2355-2363, 1999.